C
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Price:
75 900 KRW
-5.6%
Market Closed
Updated:
May 11, 2024
P/S
Price to Sales
Price to Sales
5.9
Current
5.6
Median
2.4
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=5.9
Market Cap
/
12.2T
Revenue
2.1T
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
73.3B USD | 0.2 | |
| US |
|
Cencora Inc
NYSE:COR
|
44.8B USD | 0.2 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.3B USD | 0.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.8 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.1B HKD | 0.1 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.8B EUR | 3.4 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
58.5B CNY | 1.5 | |
| CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.6B CNY | 0.2 | |
| DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
5.1
2-Years Forward
P/S
4
3-Years Forward
P/S
3.8
You don't have any saved screeners yet
